Official 2024 U.S. DOL Form 5500 summary for Rigel Pharmaceuticals INC. (Rigel Pharmaceuticals INC. 401k Plan · EIN 94-3248524 · PN 001): $64.26M net assets, 164 active participants, and $4.19 per $10,000 (4.19 bps).
| Plan Sponsor | Rigel Pharmaceuticals INC. |
|---|---|
| Filing Identifier | Rigel Pharmaceuticals INC. 401k Plan · EIN 94-3248524 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (CA) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $64.26M |
| Active Participants | 164 |
| Direct Admin Fee Rate | $4.19 per $10,000 (4.19 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI